Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring

Breast cancer affects approximately 12 % women worldwide and results in 14 % of all cancer-related fatalities. Breast cancer is commonly categorized into one of four main subtypes (luminal A, luminal B, human epidermal growth factor receptor 2 (HER2) positive and basal), indicating molecular charact...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuire, Andrew, Brown, James A. L., Kerin, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368851/
https://www.ncbi.nlm.nih.gov/pubmed/25721950
http://dx.doi.org/10.1007/s10555-015-9551-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368851/
https://www.ncbi.nlm.nih.gov/pubmed/25721950
http://dx.doi.org/10.1007/s10555-015-9551-7

Ejemplares similares